UBS holds ILS target at 1% while adding cat bonds

Catastrophe bond pricing has settled back toward historical averages, yet UBS Asset Management is still finding reasons to buy inside a reinsurance sleeve it cut from 3% to 1% at the start of 2026. The firm's Unified Global Alternatives team plans a marginal increase in catastrophe bonds within that sleeve, according to Artemis, because the carry on offer still clears the bar set by most other income and credit trades. The cap has not moved.

The team gave reinsurance and ILS a 3% portfolio weighting in 2024 and 2025, then cut that forward-looking target to 1% at the start of 2026, where it remains for the third quarter. The new money is earmarked specifically for cat bonds rather than the broader ILS category—a distinction the team's own history makes meaningful, since it held particularly high conviction in ILS while spreads and returns were exceptionally high and moved client and strategy portfolios repeatedly to chase opportunity across asset classes.

Alongside a marginal increase in corporate long/short within its credit and income book, the team said that for more neutral portfolios, catastrophe bonds within reinsurance remain attractive relative to most carry strategies. At a moment when the team's own commentary points to record-tight credit spreads, cat bonds still hold up against the alternatives, and the fact that the 1% cap has not been lifted makes the comparison deliberate.

The distinction matters because the 3% weight of 2024 and 2025 reflected the hard market's elevated spreads and the high conviction the team carried while those returns were available; the cut to 1% suggests that opportunity has largely passed. The marginal increase is a separate indication: at normalized pricing, cat bonds still clear the bar set by other carry trades, which is why Artemis described the move as evidence of the quality of returns still possible from the asset class on a relative basis.

The structural appeal is unchanged: for large investors, a sleeve of reinsurance and cat bonds delivers returns that are relatively uncorrelated with almost everything else, while the collateral behind cat bonds and other ILS is typically invested in risk-free assets such as U.S. Treasuries, adding a risk-free return component that tracks broader macro trends. Those features explain why the asset still earns a slot in a neutral portfolio even after spreads have compressed, and the same mechanics generate the carry the team is pointing to, since holding these assets over time produces income that is getting harder to find elsewhere in the current fixed-income market.

The deeper story is the cap. A manager who believed ILS was the best carry trade in the market would be raising the target, not shuffling within it; UBS is holding its 1% ceiling while tilting the composition of the sleeve toward cat bonds, which is exactly the posture the market should be watching as the soft cycle matures.

The test for reinsurance capital, as this publication has argued, is whether pricing discipline survives after the hard market's returns fade. UBS's decision is a small, instructive data point: the overall target stays clipped, even as the relative-value math inside the sleeve points toward cat bonds. The manager wants the asset, just not more of it.

Watch whether the 1% target moves when the team next revisits its allocations. If the marginal increase becomes a full restoration of the prior 3% weighting, the relative-value case will have turned into a conviction call. For now, it is a measured nibble—and in an environment where the team still sees cat bonds as the better relative carry, a measured nibble may be the strongest endorsement available.